These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 25666645)

  • 1. NAFLD. Accurate quantification of hepatic fat--is it important?
    Adams LA
    Nat Rev Gastroenterol Hepatol; 2015 Mar; 12(3):126-7. PubMed ID: 25666645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat Using a New Quantitative Ultrasound Technique.
    Lin SC; Heba E; Wolfson T; Ang B; Gamst A; Han A; Erdman JW; O'Brien WD; Andre MP; Sirlin CB; Loomba R
    Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1337-1345.e6. PubMed ID: 25478922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease.
    Chan WK; Nik Mustapha NR; Mahadeva S
    J Gastroenterol Hepatol; 2014; 29(7):1470-6. PubMed ID: 24548002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment.
    Oh H; Jun DW; Saeed WK; Nguyen MH
    Clin Mol Hepatol; 2016 Sep; 22(3):327-335. PubMed ID: 27729634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging evaluation of non-alcoholic fatty liver disease: focused on quantification.
    Lee DH
    Clin Mol Hepatol; 2017 Dec; 23(4):290-301. PubMed ID: 28994271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI versus histological methods for time course monitoring of steatosis amount in a murine model of NAFLD.
    Leiber LM; Boursier J; Michalak S; Roullier V; Fizanne L; Chaigneau J; Roux J; Moal V; Flamment M; Bazeries P; Ducluzeau PH; Aube C
    Diagn Interv Imaging; 2015 Sep; 96(9):915-22. PubMed ID: 25934180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: assessment of non-invasive indices predicting hepatic steatosis and fibrosis.
    Polyzos SA; Goulis DG; Kountouras J; Mintziori G; Chatzis P; Papadakis E; Katsikis I; Panidis D
    Hormones (Athens); 2014; 13(4):519-31. PubMed ID: 25402369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease.
    Idilman IS; Keskin O; Celik A; Savas B; Elhan AH; Idilman R; Karcaaltincaba M
    Acta Radiol; 2016 Mar; 57(3):271-8. PubMed ID: 25855666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to Diagnose Nonalcoholic Fatty Liver Disease.
    de Alwis NM; Anstee QM; Day CP
    Dig Dis; 2016; 34 Suppl 1():19-26. PubMed ID: 27547937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions.
    Clemente MG; Mandato C; Poeta M; Vajro P
    World J Gastroenterol; 2016 Sep; 22(36):8078-93. PubMed ID: 27688650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of hepatic fat: Which reference should be the reference?
    Ronot M; Van Beers BE; Vilgrain V
    Diagn Interv Imaging; 2015 Sep; 96(9):841-2. PubMed ID: 26348283
    [No Abstract]   [Full Text] [Related]  

  • 12. MRI in identifying hepatic steatosis in obese children and relation to ultrasonography and metabolic findings.
    Pozzato C; Radaelli G; Dall'Asta C; Verduci E; Villa A; Villa C; Scaglioni S; Riva E; Pontiroli AE; Cornalba G; Giovannini M
    J Pediatr Gastroenterol Nutr; 2008 Oct; 47(4):493-9. PubMed ID: 18852643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of sequential proton density fat fraction for quantification of hepatic steatosis in nonalcoholic fatty liver disease.
    Idilman IS; Keskin O; Elhan AH; Idilman R; Karcaaltincaba M
    Scand J Gastroenterol; 2014 May; 49(5):617-24. PubMed ID: 24694249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of prediction scores and novel biomarkers for predicting nonalcoholic fatty liver disease in obese children.
    Koot BG; van der Baan-Slootweg OH; Bohte AE; Nederveen AJ; van Werven JR; Tamminga-Smeulders CL; Merkus MP; Schaap FG; Jansen PL; Stoker J; Benninga MA
    Obesity (Silver Spring); 2013 Mar; 21(3):583-90. PubMed ID: 23592667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methods for assessing intrahepatic fat content and steatosis.
    Fabbrini E; Conte C; Magkos F
    Curr Opin Clin Nutr Metab Care; 2009 Sep; 12(5):474-81. PubMed ID: 19550313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology.
    Calvo N; Beltrán-Debón R; Rodríguez-Gallego E; Hernández-Aguilera A; Guirro M; Mariné-Casadó R; Millá L; Alegret JM; Sabench F; del Castillo D; Vinaixa M; Rodríguez MÀ; Correig X; García-Álvarez R; Menendez JA; Camps J; Joven J
    World J Gastroenterol; 2015 Jun; 21(24):7529-44. PubMed ID: 26140000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease.
    Park CC; Nguyen P; Hernandez C; Bettencourt R; Ramirez K; Fortney L; Hooker J; Sy E; Savides MT; Alquiraish MH; Valasek MA; Rizo E; Richards L; Brenner D; Sirlin CB; Loomba R
    Gastroenterology; 2017 Feb; 152(3):598-607.e2. PubMed ID: 27911262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similarities and differences between pediatric and adult nonalcoholic fatty liver disease.
    Crespo M; Lappe S; Feldstein AE; Alkhouri N
    Metabolism; 2016 Aug; 65(8):1161-71. PubMed ID: 26961580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sonographic quantification of a hepato-renal index for the assessment of hepatic steatosis in comparison with 3T proton magnetic resonance spectroscopy.
    Martín-Rodríguez JL; Arrebola JP; Jiménez-Moleón JJ; Olea N; González-Calvin JL
    Eur J Gastroenterol Hepatol; 2014 Jan; 26(1):88-94. PubMed ID: 23921844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver.
    Yamada H; Suzuki K; Ichino N; Ando Y; Sawada A; Osakabe K; Sugimoto K; Ohashi K; Teradaira R; Inoue T; Hamajima N; Hashimoto S
    Clin Chim Acta; 2013 Sep; 424():99-103. PubMed ID: 23727030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.